Green Cross Health (NZSE:GXH) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NZSE:GXH Green Cross Health Ltd NZSE:GXH
63 GF Score
Price NZ$1.96
GF Value NZ$1.08
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Green Cross Health Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Green Cross Health Valuation Rank Related Terms

NZSE:GXH
63GF Score
Green Cross Health Ltd NZSE:GXH
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Green Cross Health (NZSE:GXH) Overvalued in 2026?

Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued. The current stock price of NZ$1.96 is trading 81.5% above its estimated GF Value™ of NZ$1.08. GuruFocus considers Green Cross Health to be Significantly Overvalued.

Key valuation signals for NZSE:GXH:

  • Valuation Rank:
  • GF Value™: NZ$1.08 vs. price of NZ$1.96 (81.5% above fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Green Cross Health Business Description

Address 602 Great South Road, Ellerslie, Ground Floor, Building B, Millennium Centre, Auckland, NTL, NZL, 1051
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
63GF Score

Get the complete analysis for NZSE:GXH

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$1.96
Price
NZ$1.08
GF Value